Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kacie A Gardella

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Aging|July 29, 2016
Lymphoid malignancies ARNT unstoppableKacie A Gardella, Richa Tiwary, Casey W Wright
Cell Cycle (Georgetown, Tex.)|April 18, 2014
The TRAF3 adaptor protein drives proliferation of anaplastic large cell lymphoma cells by regulating multiple signaling pathwaysIsrael Muro, Gloria Fang, Kacie A Gardella, et al.
Oncotarget|February 25, 2016
Aryl hydrocarbon receptor nuclear translocator (ARNT) isoforms control lymphoid cancer cell proliferation through differentially regulating tumor suppressor p53 activityKacie A Gardella, Israel Muro, Gloria Fang, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Aging|July 29, 2016
Lymphoid malignancies ARNT unstoppableKacie A Gardella, Richa Tiwary, Casey W Wright
Cell Cycle (Georgetown, Tex.)|April 18, 2014
The TRAF3 adaptor protein drives proliferation of anaplastic large cell lymphoma cells by regulating multiple signaling pathwaysIsrael Muro, Gloria Fang, Kacie A Gardella, et al.
Oncotarget|February 25, 2016
Aryl hydrocarbon receptor nuclear translocator (ARNT) isoforms control lymphoid cancer cell proliferation through differentially regulating tumor suppressor p53 activityKacie A Gardella, Israel Muro, Gloria Fang, et al.
Pageof 1